In an announcement on Monday, Illumina Inc. (NASDAQ: ILMN) said it will pay £6.25 billion in cash and stock to buy Grail Inc. The deal will see Illumina buying out Grail’s investors, including CEO Jeff Bezos of Amazon Inc. Illumina had spun out the cancer screening start-up in 2016. Illumina was reported trading about 15% down in premarket trading on Monday. Shares of the company recovered slightly in the morning session but lost the gain before the market close. Illumina now has a per-share price of £209 that represents close to a 30% recovery since March when the stock
Full ArticleIllumina expresses plans of acquiring Grail Inc. for £6.25 billion
Invezz
0 shares
1 views
You might like
Related news coverage
Nikola, Illumina fall; Cubic, Rent-A-Center rise
SeattlePI.com
NEW YORK (AP) — JPMorgan Chase & Co., down $3.04 to $95.31.
The bank allegedly continued profiting from illicit..
-
US stocks tank as coronavirus fears rekindle
Proactive Investors
-
US benchmarks crashing, while FTSE 100 closes 3.4% lower as coronavirus fears rise
Proactive Investors
-
Illumina to acquire Peninsula cancer detection biotech Grail in $8 billion deal
bizjournals
-
US benchmarks tank at open as markets fearful of rising coronavirus cases
Proactive Investors
Advertisement
More coverage
Illumina To Acquire GRAIL In $8 Bln Cash, Stock Deal
RTTNews
Biotech company Illumina agreed to buy healthcare company GRAIL, Inc. in a cash and stock deal valued at $8 billion. This includes..